title: Using high quality clinical databases to complement the results of randomised controlled trials: the case of recombinant human activated protein C.
authors.affiliation: Health Services Research Unit, Department of Public Health and Policy, London School of Hygiene, London, UK. Andrew.Padkin@lshtm.ac.uk
authors.forename: A
authors.initials: A
authors.lastname: Padkin
authors.forename: K
authors.initials: K
authors.lastname: Rowan
authors.forename: N
authors.initials: N
authors.lastname: Black
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D002985:Clinical Protocols; D003422:Critical Care / Q000379:methods*; D016208:Databases, Factual; D019317:Evidence-Based Medicine / Q000379:methods*; D006801:Humans; D011050:Policy Making; D011486:Protein C / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000627:therapeutic use; D018805:Sepsis / Q000188:drug therapy*
chemical_list: D000925:Anticoagulants; D011486:Protein C; D011994:Recombinant Proteins